Citius Oncology Inc (CTOR)
1.19
+0.01
(+0.85%)
USD |
NASDAQ |
Oct 04, 16:00
1.19
0.00 (0.00%)
After-Hours: 20:00
Citius Oncology Shareholders Equity (Annual)
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 25.54M |
| Date | Value |
|---|---|
| September 30, 2022 | 36.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
25.54M
Minimum
2023
36.27M
Maximum
2022
30.90M
Average
30.90M
Median
Shareholders Equity (Annual) Benchmarks
| Citius Pharmaceuticals Inc | 90.83M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |